R-Pharm and the Russian Venture Company invested $ 4 million in the American company Bonti, which develops drugs for aesthetic medicine, and will receive up to $ 20 million when it is sold to the Irish giant Allergan.
Veronika Skvortsova's office has already filed 16 lawsuits against the company R-Pharm.
Three antitrust cases have already been initiated against Alexey Repik's R-Pharm.
The businessman bought a plant of accelerators for radiation therapy in Dubna (Moscow region).
The company lost the dispute to Native.
The son-in-law of Foreign Minister Sergei Lavrov and the raider in combination intend to reshape the pharmacy business in Russia in his favor.
The Ministry of Health of the Russian Federation responded to suspicions of the Federal Antimonopoly Service (FAS) in collusion with R-Pharm. The department does not understand which part of the antimonopoly legislation was violated, and the FAS verification is called biased.
Suddenly, the clear-sighted antimonopoly service suspected the Ministry of Health in unusually generous preferences for the company "R-Pharm."
In Russia, the pharmaceutical market is being monopolized, which will lead to a sharp rise in prices for medicines for the population.
The multi-billion government contracts are obtained by mysterious contractors without tenders.
There's no competition in many tenders, so the orders are placed at the maximum price.